PELP1 and AIB1 cooperate to promote breast cancer progression in ER plus breast cancer models.

被引：0
|
作者：
Truong, Thu H. [1 ]
Hu, Hsiangyu [1 ]
Ostrander, Julie H. [1 ]
Lange, Carol A. [1 ]
机构：
[1] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA
来源：
MOLECULAR CANCER RESEARCH | 2018年 / 16卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A30
引用
收藏
页码：40 / 41
页数：2
相关论文
共 50 条
  • [11] PELP1 regulation of mTOR Axis: Role in breast cancer progression and resistance
    Gonugunta, Vijaya Kumar
    Valerie, Cortez
    Roy, Sudipa Saha
    Sareddy, Gangadhar Reddy
    Nair, Binoj C.
    Vadlamudi, Ratna K.
    CANCER RESEARCH, 2012, 72
  • [12] Significance and therapeutic potential of PELP1 axis in ER-negative breast cancer
    Vadlamudi, Ratna K.
    Roy, Sudipa Saha
    CANCER RESEARCH, 2011, 71
  • [13] Expression of AIB1 protein as a prognostic factor in breast cancer
    Kyungji Lee
    Ahwon Lee
    Byung Joo Song
    Chang Suk Kang
    World Journal of Surgical Oncology, 9
  • [14] Clinical significance of AIB1 expression in human breast cancer
    Iwase, H
    Omoto, Y
    Toyama, T
    Yamashita, H
    Hara, Y
    Sugiura, H
    Zhang, Z
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 80 (03) : 339 - 345
  • [15] Expression of AIB1 protein as a prognostic factor in breast cancer
    Lee, Kyungji
    Lee, Ahwon
    Song, Byung Joo
    Kang, Chang Suk
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2011, 9
  • [16] Significance of PELP1 signaling in liver cancer progression
    Pratap, Uday
    Nassar, Khaled Mohamed
    Yang, Xue
    Baker, Adriana
    Gopalam, Rahul
    Arnold, William C.
    Adeniran, Timilehin
    Hernandez Fernandez, Marian Helena
    Sareddy, Gangadhara R.
    Viswanadhapalli, Suryavathi
    Sun, Luzhe
    Vadlamudi, Ratna K.
    CANCER RESEARCH, 2024, 84 (06)
  • [17] Clinical Significance of AIB1 Expression in Human Breast Cancer
    H. Iwase
    Y. Omoto
    T. Toyama
    H. Yamashita
    Y. Hara
    H. Sugiura
    Z. Zhang
    Breast Cancer Research and Treatment, 2003, 80 : 339 - 345
  • [18] Loss of ANCO1 repression at AIB1/YAP targets drives breast cancer progression
    Kushner, Max H.
    Ory, Virginie
    Graham, Garrett T.
    Sharif, Ghada M.
    Kietzman, William B.
    Thevissen, Sophia
    Yuan, Meng
    Schmidt, Marcel O.
    Wellstein, Anton
    Riegel, Anna T.
    EMBO REPORTS, 2020, 21 (01)
  • [19] The Clinical Value of PELP1 for Breast Cancer: A Comparison with Multiple Cancers and Analysis in Breast Cancer Subtypes
    Wang, Xingen
    Tsang, Julia Y. S.
    Lee, Michelle A.
    Ni, Yun-Bi
    Tong, Joanna H.
    Chan, Siu-Ki
    Cheung, Sai-Yin
    To, Ka Fai
    Tse, Gary M.
    CANCER RESEARCH AND TREATMENT, 2019, 51 (02): : 706 - 717
  • [20] The role of AIB1 and PAX2 in primary breast cancer: validation of AIB1 as a negative prognostic factor
    Alkner, S.
    Bendahl, P. O.
    Grabau, D.
    Malmstrom, P.
    Ferno, M.
    Ryden, L.
    ANNALS OF ONCOLOGY, 2013, 24 (05) : 1244 - 1252
12345